Semaglutide is marketed under popular names like Wegovy, which is tailored for weight loss, and Ozempic, for managing type 2 diabetes
Published Dec
Phase 3 TRIUMPH-4 (NCT05931367) reported 28.7% body weight loss at 12 mg, 26.4% at 9 mg, vs 2.1% placebo at 68 weeks
One of the most popular treatments we offer is Xeomin, a neuromodulator similar to Botox
j , AUC quantification of calcium recordings ( n = 6 mice per condition, paired t-test)
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management